Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - metyrapone, quantity: 250 mg - capsule, soft - excipient ingredients: macrogol 400; sodium ethyl hydroxybenzoate; sodium propyl hydroxybenzoate; macrogol 4000; glycerol; gelatin; purified water; acetanisole; ethyl vanillin; titanium dioxide; propylene glycol; hypromellose; isopropyl alcohol; aluminium chloride; sodium hydroxide; cochineal - diagnostic use,? for the diagnosis of latent acth deficiency such as in cases of known pituitary dysfunction or of a suspected pituitary tumour, as well as before and after surgical intervention in the region of the pituitary; and, to assess the degree of acth suppression during or after glucocorticoid therapy.,? for the differential diagnosis of states of adrenocortical hyperfunction in cushing's syndrome.

New Zealand - English - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - budesonide 3mg - modified release capsule - 3 mg - active: budesonide 3mg excipient: acetyl tributyl citrate ethylcellulose gelatin methacrylic acid - ethyl acrylate copolymer polysorbate 80 purified talc simeticone sugar spheres triethyl citrate - entocort capsules are indicated for the induction of remission in patients with mild to moderate crohn's disease affecting the ileum and/or the ascending colon.

New Zealand - English - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - deferiprone 500mg;   - film coated tablet - 500 mg - active: deferiprone 500mg   excipient: colloidal silicon dioxide hypromellose macrogol 3350 magnesium stearate microcrystalline cellulose titanium dioxide - ferriprox is indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy or in whom desferrioxamine therapy has proven ineffective.

New Zealand - English - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - deferiprone 100 mg/ml;   - oral solution - 100 mg/ml - active: deferiprone 100 mg/ml   excipient: cherry flavour 33.12676 glycerol hydrochloric acid hyetellose peppermint oil purified water sucralose sunset yellow fcf - ferriprox is indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy or in whom desferrioxamine therapy has proven ineffective.

New Zealand - English - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - metyrapone 250mg - soft gelatin capsule - 250 mg - active: metyrapone 250mg excipient: acetanisole ethyl hydroxybenzoate as the sodium salt ethyl vanillin gelatin glycerol   ink macrogol 400 macrogol 4000 purified water sodium propyl hydroxybenzoate titanium dioxide - therapeutic applications metopirone can be employed as supplementary therapy in conditions associated with overproduction of glucocorticoids and mineralocorticoids, particularly when causal treatment is not possible. cushing's syndrome, especially when related to adrenal tumours hyperaldosteronism, resistant oedema

New Zealand - English - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - salcatonin 100 iu/ml;  ;   - solution for injection - 100 iu/ml - active: salcatonin 100 iu/ml     excipient: glacial acetic acid nitrogen sodium acetate trihydrate sodium chloride water for injection - acute bone pain associated with hip arthroplasty osteolysis and osteoporotic vertebral compression fracture.

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - beclometasone dipropionate - nebuliser suspension - 800 mcg/2 millilitre(s) - glucocorticoids; beclometasone

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - beclometasone dipropionate - nebuliser suspension - 400 mcg/1 millilitre(s) - glucocorticoids; beclometasone

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - beclometasone dipropionate - nebuliser suspension - 400 millilitre(s) - glucocorticoids; beclometasone

Ireland - English - HPRA (Health Products Regulatory Authority)

chiesi farmaceutici s.p.a. - beclometasone dipropionate - nebuliser suspension - 800 µg/2ml - glucocorticoids; beclometasone